153 related articles for article (PubMed ID: 3107042)
1. L-dopa causes an acute, partial and reversible reversal of denervation-induced supersensitivity of striatal dopaminergic receptors.
Ferre S; Casas M; Cobos A; Garcia C; Jane F; Grau JM
Psychopharmacology (Berl); 1987; 91(2):254-6. PubMed ID: 3107042
[TBL] [Abstract][Full Text] [Related]
2. 3-O-methyl-DOPA is not involved in the development of behavioral supersensitivity after repeated L-dopa administration in 6-OHDA lesioned rats.
Bräutigam K; Sohr R; Morgenstern R
Behav Brain Res; 1994 Jul; 63(1):41-5. PubMed ID: 7945976
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor changes in response to prolonged treatment with L-dopa.
Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
[TBL] [Abstract][Full Text] [Related]
4. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
Groppetti A; Ceresoli G; Mandelli V; Parenti M
J Pharmacol Exp Ther; 1990 Jun; 253(3):950-6. PubMed ID: 2162953
[TBL] [Abstract][Full Text] [Related]
5. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
[TBL] [Abstract][Full Text] [Related]
6. Supersensitivity of the cholinergic response to apomorphine in the striatum following denervation or disuse supersensitivity of dopaminergic receptors in the rat.
Consolo S; Ladinsky H; Samanin R; Bianchi S; Ghezzi D
Brain Res; 1978 Oct; 155(1):45-54. PubMed ID: 210895
[No Abstract] [Full Text] [Related]
7. Early L-dopa treatment initially retards but later enhances dopamine receptor supersensitivity following unilateral dopamine denervation.
Carey RJ; Pinheiro-Carrera M; Tomaz C; Huston JP
Brain Res; 1994 Sep; 658(1-2):145-54. PubMed ID: 7834335
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with 1-dopa plus carbidopa in hemitransected rats: preferential effects at intact dopamine synapses leading to behavioural signs of dopamine receptor supersensitivity.
Agnati LF; Fuxe K; Calza L; Zini I; Benefenati F; Farabegoli C; Goldstein M
Acta Physiol Scand; 1983 May; 118(1):27-34. PubMed ID: 6137934
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
[TBL] [Abstract][Full Text] [Related]
10. Behavioral quantification of striatal dopaminergic supersensitivity after bilateral 6-hydroxydopamine lesions in the mouse.
Mandel RJ; Wilcox RE; Randall PK
Pharmacol Biochem Behav; 1992 Feb; 41(2):343-7. PubMed ID: 1574523
[TBL] [Abstract][Full Text] [Related]
11. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.
Thornburg JE; Moore KE
J Pharmacol Exp Ther; 1975 Jan; 192(1):42-9. PubMed ID: 1168250
[TBL] [Abstract][Full Text] [Related]
12. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
Globus M; Bannet J; Lerer B; Belmaker RH
Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701
[TBL] [Abstract][Full Text] [Related]
13. The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.
Blunt S; Jenner P; Marsden CD
Neuroscience; 1991; 40(2):453-64. PubMed ID: 1902916
[TBL] [Abstract][Full Text] [Related]
14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
15. The sialagogue response of striatal dopamine receptors to L-dopa is not influenced by castration or chronic estrogen treatment.
Pazo JH; Gomez-Gonzales M; Tumilasci OR; O'Donnell P; Murer G
Brain Res Bull; 1986 Jan; 16(1):1-4. PubMed ID: 3955384
[TBL] [Abstract][Full Text] [Related]
16. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
[TBL] [Abstract][Full Text] [Related]
17. Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.
Globus M; Melamed E
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):211-5. PubMed ID: 6310691
[TBL] [Abstract][Full Text] [Related]
18. Rapid reversal of denervation supersensitivity of dopamine D1 receptors by l-dopa or a novel dopamine D1 receptor agonist, A68930.
Britton DR; Kebabian JW; Curzon P
Eur J Pharmacol; 1991 Jul; 200(1):89-93. PubMed ID: 1685124
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
20. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
Ferretti C; Ghi P; Blengio M; Gaietta G; Barrera G; Genazzani E
Eur J Pharmacol; 1989 Jul; 166(2):149-56. PubMed ID: 2551698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
